Sight Sciences Inc (SGHT)

02:13 AM

Sight Sciences (SGHT) to Release Earnings on Thursday - Defense World

02:13 AM

Apr 23, 2025

Sight Sciences Announces the Release of its Sustainability Report - GlobeNewswire

Apr 23, 2025

Apr 23, 2025

Sight Sciences Sustainability Report Reveals Strong Gender Pay Equity, 14% Staff Retention Boost - Stock Titan

Apr 23, 2025

Apr 23, 2025

Sight Sciences Appoints Gary Burbach to Board of Directors - VisionMonday.com

Apr 23, 2025

Apr 22, 2025

Sight Sciences appoints new board member By Investing.com - Investing.com India

Apr 22, 2025

Apr 22, 2025

Sight Sciences appoints new board member - Investing.com

Apr 22, 2025

Apr 22, 2025

Sight Sciences Appoints Gary Burbach to its Board of Directors - The Manila Times

Apr 22, 2025

Apr 22, 2025

Sight Sciences Strengthens Board with Medtech Veteran as Glaucoma, Dry Eye Markets Transform - Stock Titan

Apr 22, 2025

Apr 21, 2025

Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment - Nasdaq

Apr 21, 2025

Apr 21, 2025

Sight Sciences to Debut OMNI® Edge Surgical System at the - GlobeNewswire

Apr 21, 2025

Apr 21, 2025

Sight Sciences Unveils OMNI Edge: Next-Gen Glaucoma Surgery System with 2X Capacity | SGHT Stock News - Stock Titan

Apr 21, 2025

Apr 15, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by American Century Companies Inc. - Defense World

Apr 15, 2025

Apr 11, 2025

Sight Sciences (NASDAQ:SGHT) Earns Hold Rating from Needham & Company LLC - Defense World

Apr 11, 2025

Apr 11, 2025

Sight sciences CTO David Badawi sells $15,081 in stock - MSN

Apr 11, 2025

Apr 10, 2025

April 2025's Top Penny Stocks To Watch - simplywall.st

Apr 10, 2025

Apr 10, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Apr 10, 2025

Apr 08, 2025

Sight Sciences at 24th Annual Needham Conference: Strategic Growth Insights - Investing.com Canada

Apr 08, 2025

Apr 04, 2025

Sight sciences chief commercial officer sells $11,641 in stock By Investing.com - Investing.com India

Apr 04, 2025

Apr 03, 2025

Sight Sciences stock hits 52-week low at $2.13 amid market challenges - Investing.com

Apr 03, 2025

Apr 03, 2025

Sight sciences chief commercial officer sells $11,641 in stock - Investing.com

Apr 03, 2025

Apr 03, 2025

Sight sciences CEO Paul Badawi sells shares worth $55,672 By Investing.com - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Sight sciences CTO David Badawi sells $13,771 in common stock By Investing.com - Investing.com India

Apr 03, 2025

Apr 03, 2025

Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 By Investing.com - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 - Investing.com

Apr 03, 2025

Apr 03, 2025

Sight sciences CTO David Badawi sells $13,771 in common stock - Investing.com

Apr 03, 2025

Apr 03, 2025

Sight Sciences chief legal officer sells $21,693 in stock - Investing.com

Apr 03, 2025

Apr 03, 2025

Sight Sciences chief legal officer sells $21,693 in stock By Investing.com - Investing.com UK

Apr 03, 2025

Apr 03, 2025

Sight Sciences Executives Sell Shares to Cover Tax Liabilities - TradingView

Apr 03, 2025

Apr 03, 2025

Sight Sciences stock hits 52-week low at $2.13 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Short Interest Update - Defense World

Apr 03, 2025

Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Mar 31, 2025

Mar 30, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st

Mar 30, 2025

Mar 29, 2025

Sight sciences chief legal officer sells shares worth $19,250 - MSN

Mar 29, 2025

Mar 26, 2025

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire

Mar 26, 2025

Mar 25, 2025

Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan

Mar 25, 2025

Mar 25, 2025

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 25, 2025

Mar 16, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World

Mar 16, 2025

Mar 15, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 13, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India

Mar 13, 2025

Mar 09, 2025

Piper Sandler Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.50 - Defense World

Mar 09, 2025

Mar 09, 2025

Sight Sciences’ (SGHT) Hold Rating Reiterated at Needham & Company LLC - Defense World

Mar 09, 2025

Mar 08, 2025

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics - MSN

Mar 08, 2025

Mar 08, 2025

Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025

Mar 08, 2025

Stifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025

Mar 08, 2025

Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts By Investing.com - Investing.com Australia

Mar 08, 2025

Mar 07, 2025

Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Mar 07, 2025

Mar 07, 2025

Sight Sciences Inc. (SGHT) reports earnings - Quartz

Mar 07, 2025

Mar 07, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results, Initiates Full Year 2025 Financial Guidance - Vision Monday

Mar 07, 2025

Mar 06, 2025

Sight Sciences Faces Headwinds in Glaucoma and Dry Eye Markets, Hold Rating Maintained - TipRanks

Mar 06, 2025

Mar 06, 2025

Sight Sciences’ Earnings Call: Cautious Optimism Amid Challenges - TipRanks

Mar 06, 2025

Mar 06, 2025

Sight Sciences price target lowered to $3.50 from $5.50 at Piper Sandler - TipRanks

Mar 06, 2025

Mar 06, 2025

Stifel cuts Sight Sciences price target to $4, maintains Buy rating By Investing.com - Investing.com South Africa

Mar 06, 2025

Mar 06, 2025

Stifel cuts Sight Sciences price target to $4, maintains Buy rating - Investing.com

Mar 06, 2025